Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Randomized Parallel Group Phase IV Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen.

NCT03742232 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.

NCT NCT03742232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03742232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Randomized Parallel Group Phase IV Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen.
Lead sponsor
Istituto Clinico Humanitas
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2018
Completion date
March 31, 2020
Enrollment
399 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

colon adenoma, colon lesion, colon polyp